XENON PHARMACEUTICALS INC (XENE) Earnings History & Surprises
NASDAQ:XENE • CA98420N1050
43.05 USD
-0.74 (-1.69%)
At close: Mar 4, 2026
43.05 USD
0 (0%)
After Hours: 3/4/2026, 5:38:57 PM
Past quarterly earnings results for XENON PHARMACEUTICALS INC (XENE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 11, 2026
PeriodQ1 / 2026
EPS Estimate-$1.22
Revenue Estimate
Last Reported
Release DateFeb 26, 2026
PeriodQ4 / 2025
EPS Reported-$1.31
EPS Surprise -7.80%
Revenue Surprise %
Beat Rate
38%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.31 | -1.22 | -7.80% | -55.95% | - | - | ||
| Q3 2025 | -1.15 | -1.18 | 2.13% | -41.98% | - | - | ||
| Q2 2025 | -1.07 | -1.01 | -5.82% | -42.67% | - | - | ||
| Q1 2025 | -0.83 | -0.93 | 10.75% | -33.87% | 7.5M | 1.129M | 564.30% | - |
| Q4 2024 | -0.84 | -0.88 | 4.31% | -31.25% | 339.997K | -100.00% | - | |
| Q3 2024 | -0.81 | -0.83 | 2.60% | -10.96% | - | - | ||
| Q2 2024 | -0.75 | -0.71 | -5.10% | -4.17% | - | - | ||
| Q1 2024 | -0.62 | -0.68 | 8.49% | 1.59% | - | - | ||
| Q4 2023 | -0.64 | -0.77 | 17.35% | -12.28% | 1.93M | -100.00% | - | |
| Q3 2023 | -0.73 | -0.79 | 7.55% | -28.07% | 1.479M | -100.00% | -100.00% | |
| Q2 2023 | -0.72 | -0.71 | -1.23% | -30.91% | 408K | -100.00% | -100.00% | |
| Q1 2023 | -0.63 | -0.63 | 0.64% | -80.00% | 582.859K | -100.00% | -100.00% | |
| Q4 2022 | -0.57 | -0.60 | 4.45% | -18.75% | 2.329M | -100.00% | -100.00% | |
| Q3 2022 | -0.57 | -0.53 | -8.16% | -58.33% | 130K | 3.079M | -95.78% | -98.40% |
| Q2 2022 | -0.55 | -0.49 | -11.64% | -7.84% | 540K | 3.626M | -85.11% | -75.68% |
| Q1 2022 | -0.35 | -0.41 | 15.39% | 16.67% | 8.77M | 8.874M | -1.17% | 101.15% |
| Q4 2021 | -0.48 | -0.38 | -26.96% | -41.18% | 3.74M | 5.075M | -26.31% | -27.38% |
| Q3 2021 | -0.36 | -0.39 | 7.93% | -44.00% | 8.12M | 10.43M | -22.15% | 23.97% |
| Q2 2021 | -0.51 | -0.49 | -4.44% | - | 2.22M | 2.375M | -6.53% | -83.41% |
| Q1 2021 | -0.42 | -0.44 | 4.79% | -90.91% | 4.36M | 3.026M | 44.08% | -38.42% |
| Q4 2020 | -0.34 | -0.41 | 16.61% | - | 5.15M | 3.28M | 57.01% | - |
| Q3 2020 | -0.25 | -0.15 | -61.86% | - | 6.55M | 10.257M | -36.14% | - |
| Q2 2020 | 0.00 | -0.24 | 100.00% | - | 13.38M | 7.037M | 90.14% | - |
| Q1 2020 | -0.22 | -0.33 | 33.06% | - | 7.08M | 4.59M | 54.25% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
2.84%
Max EPS beat (4)
10.75%
Min EPS beat (4)
-5.82%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, XENE has beaten EPS estimates in 3 out of 4 releases
In the last 4 quarters, XENE has beaten the EPS estimates by 2.8% on average.
XENON PHARMACEUTICALS INC / XENE Earnings FAQ
When did XENON PHARMACEUTICALS INC (XENE) report earnings last quarter?
XENON PHARMACEUTICALS INC (XENE) last reported earnings on 2/26/2026.
Can you provide information on whether XENON PHARMACEUTICALS INC beat earnings estimates in the last quarter?
XENON PHARMACEUTICALS INC (XENE) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often XENON PHARMACEUTICALS INC beats earnings estimates?
In the last 4 quarters, XENON PHARMACEUTICALS INC (XENE) has beaten EPS estimates in 3 out of 4 releases.